JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB263401

Human TTLL12 knockout HEK-293T cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

TTLL12 KO cell lysate available now. KO validated by. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp deletion in exon 2.

View Alternative Names

FLJ41795, KIAA0153, TTL12_HUMAN, Tubulin tyrosine ligase like family, member 12, Tubulin--tyrosine ligase-like protein 12, dJ526I14.2

1 Images
Sanger Sequencing - Human TTLL12 knockout HEK-293T cell lysate (AB263401)
  • Sanger seq

Unknown

Sanger Sequencing - Human TTLL12 knockout HEK-293T cell lysate (AB263401)

Homozygous : 1 bp deletion in exon 2

Key facts

Cell type

HEK-293T

Species or organism

Human

Tissue

Kidney

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp deletion in exon 2.

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab263401-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human TTLL12 knockout HEK293T cell lysate", "number":"AB263401-CMP01", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HEK293T cell lysate", "number":"AB263401-CMP02", "productcode":"" } ] } } }

Properties and storage information

Gene name
TTLL12
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Zygosity
Homozygous
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

TTLL12 also known as Tubulin Tyrosine Ligase Like 12 is an enzyme that belongs to the tubulin tyrosine ligase-like (TTLL) family. This protein functions mechanically by catalyzing the polyglutamylation of target proteins especially tubulin impacting microtubule stability and interaction. TTLL12 has a mass of approximately 60 kDa and is predominantly expressed in the brain and testis although its expression is noted in other tissues as well. The involvement of TTLL12 in these tissues suggests its significance in specialized cellular processes.
Biological function summary

TTLL12 influences neuronal and cellular functions through its capacity to alter the microtubule network. It participates in the polyglutamylation activity that regulates microtubule dynamics synaptic stability and intracellular transport playing critical roles in neurodevelopment and cellular organization. Although TTLL12 itself does not commonly form large complexes its enzymatic activity impacts other microtubule-modifying complexes indirectly affecting cellular architecture and signaling pathways.

Pathways

TTLL12 participates notably in the microtubule-network pathway and the regulation of cytoskeleton organization. Its activity modulates the polymerization and depolymerization dynamics of microtubules impacting cell cycle and neuronal signaling. TTLL12's function is related to other tubulin-modifying enzymes such as TTLL1 and TTLL5 which share a role in tubulin modification thereby affecting cellular processes like mitosis and intracellular trafficking.

TTLL12's aberrant activity or expression has connections to neurodegenerative diseases and male infertility. For example its dysfunction in the brain is associated with tauopathies where improper microtubule regulation contributes to disease pathology. Additionally TTLL12's function relates to proteins like tau and other microtubule-associated proteins (MAPs) which play roles in maintaining neuronal structure and function. Understanding its connections to these conditions may shed light on potential therapeutic strategies.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com